CommercialCoverageMedium impact
07.06.03c, Bioimpedance for the Detection of Lymphedema
Independence Blue Cross·Oncology, Vascular Surgery, Plastic Surgery +2 more·Medical Policy
Effective date
Nov 17, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross updated their medical policy for bioimpedance testing used to detect lymphedema, affecting coverage criteria, reimbursement position, medical necessity requirements, and coding guidelines. This is a comprehensive policy update that impacts multiple aspects of billing for lymphedema detection procedures.
Action Required
By November 17, 2025: Billing team must review updated Independence Blue Cross policy 07.06.03c for bioimpedance lymphedema detection procedures. Update billing software with new medical necessity criteria and coverage requirements. Ensure providers understand revised documentation requirements for lymphedema detection claims to avoid denials.